Member Info for Ivyspivey

Heard on grapevine that Tiddly Ted Poe is opening up a New SUBway in Barrow in Furness as he has heard they like massive Subs.

Why all the stuff about US Georgia relations is important to FRR. You can guarantee that those US senators are pushing the FRR case via the US Giovanni. https://frontnews.eu/news/en/16403

Lindsey Graham � Georgia is the Only Country in the Neighborhood which Pursues Clearly Western Policy May 24, 2018 89 Views �Georgia is the only country in the neighborhood, which pursues clearly western policy and does it in a thoroughly reasonable and rational manner� states Lindsey Graham, Republican Senator at a meeting held with Giorgi Kvirikashvili, Prime Minister of Georgia. Mr. Graham, Senator from South Carolina gave a high appreciation to the reforms implemented by the authorities of Georgia. It was noted that level of US-Georgia economic cooperation needs to comply with political relations between the two countries. US Senator has stressed the solid support to Georgia and process of its Euro-Atlantic integration. Meeting inter alia referred to the regional challenges. Lindsey Graham reiterated his support towards the territorial integrity and sovereignty of Georgia. According to him, Georgia enjoys strong support from US Senate, as numerously demonstrated before both in its Resolutions and Consolidated Bills with supporting provisions. Senator has clearly stated that such support towards Georgia will be further intensified in future.

https://www.investegate.co.uk/tyratech--inc---tyr-/rns/final-results/201805230700109500O/

Just catching up As always WF you put things into a nice perspective. GLA

Can�t temember seeing this before.See p10 for mention of FRR https://www.csce.gov/sites/helsinkicommission.house.gov/files/unofficial-transcript/0713%20Energy%20%28In%29Security%20in%20Russias%20Periphery_Scrubbed.pdf

Agenda ~ Registration/Check-In opens at 8:30 a.m. ~ Welcoming Remarks (9:00 a.m.) Nancy Lindborg, President, United States Institute of Peace Panel 1 (9:15 a.m.- 10:45 a.m.) Geopolitics and Security: U.S.-Georgia Strategic Alliance in the Making H.E. Mikheil Janelidze, Vice Prime Minister & Minister of Foreign Affairs of Georgia Fiona Hill, Special Assistant to the President and Senior Director for European and Russian Affairs, NSC Robert Karem, U.S. Assistant Secretary of Defense for International Security � Invited Luke Coffey, Director, Douglas and Sarah Allison Center for Foreign Policy Studies, The Heritage Foundation (Moderator) Panel 2 (11:15 a.m. � 12:45 p.m.) Trade and Commerce: Georgia � Strategic Gateway for Regional Expansion H.E. Dimitry Kumsishvili, First Vice Prime Minister & Minister of Economy and Sustainable Development of Georgia Brock Bierman, Assistant Administrator for Europe and Eurasia, USAID Jonathan Katz, Senior Fellow, German Marshall Fund of the United States (Moderator) Closing Remarks (12:45 p.m.) H.E. Levan Izoria, Minister of Defense of Georgia Description This year marks the centennial of Georgia�s independence and the establishment of the First Republic in 1918 and the 10th year since the Russian invasion of Georgia in 2008. Please join the U.S. Institute of Peace, the Embassy of Georgia and The Heritage Foundation for the Second Annual U.S.-Georgia Strategic Partnership Conference as renowned experts explore the current state of regional affairs, focusing on the geopolitical interest of the United States and Georgia. The Conference will provide a unique opportunity for U.S. decision-makers, private sector leaders, experts, scholars, and journalists to focus on trends and challenges and to explore bilateral and multilateral opportunities from a regional and international perspective.

Prime Minister of Georgia Giorgi Kvirikashvili and the ministers of economy, foreign affairs and defence will visit the US from May 21-24. During his working visit PM Kvirikashvili will open the plenary meeting of the Georgia-US strategic partnership council with the US Secretary of State Mike Pompeo. Also, Kvirikashvili will take part in the US-Georgia strategic partnership annual conference which is being organised by the Heritage Foundation and the US Institute of Peace in Washington DC. On May 23 Kvirikashvili will attend the event dedicated to the 100th anniversary of the first democratic Republic of Georgia, which will be held at the US Institute of Peace in Washington DC organised by the Georgian Embassy in the US. Moreover, several bilateral meetings are planned with representatives of the executive government, as well as with the heads of various congressional committees.

Good move getting out there imo Your other choice is obviously much closer to my heart but very confident onmother one(despite placing) and CEOnis a personal friend who I will see at AGM. TC

Cheers Inanaco. I do appreciate all views and find your scientific input very informative but at end of the day it is our money and we invest accordingly. I do find an irony in my 2 LTH and biggest holdings and where I have researched a lot and base my investment purely on the fundamentals and risk/reward I am underwater( both as a resultt largely due to f recent placing) whereas my trading shares I have done much better. But like you I feel very comfortable here and happy to wait out for the long term value creation I am confident will come at six me stage

I have always been keen on SCLP and always that the potential reward here is much higher than on the other share you mention but so is the risk as they have completed phase 3.I always base my exposure in my perceived risk/reward but I have added a lot more here recently and am happy with my exposure to both. My only other slight favouring of the other one us that I am personal friends with the CEO so if I want to know anything I can ask him direct. He obviously isnot going to tell me anything material but I find having a direct line of communication to him can be helpful so rather than guessing what the plan is I can more readily find out. As for the value currently ascribed to SCLP it is what it is. I am not saying it should not be a lot higher but equally if you were to sell shares tomorrow that is the price you will get. I am happy to wait on both but equally if I get it wrong then I will readily accept it. To sum up I hold all my MTFB but have bought a lot more here with new money

Sounds very simiłar to me. Anyway good to hear you are OK-be wary if you are still VAL

Bloody hell Max if this comes in you will still have 2 jobs. 1.Counting your money and 2.Spending it lol Hope you are good mate

C7 PS Well done yesterday and onwards and upwards for this week. Have my 5 yearly MOT tomorrow in Manchester so will find out if I am condemned as an old wreck or not lol

C7 Posts crossed Listened to Re ording again and I thought sone positive things and although liked RG speaking on these occasions I think CH has got up to speed with explaining the science well and maybe has just a bit more commercial nous to take SCLP forward as it moves into a newer phase in its development. But it is early days but did feel he made a lot of references to the valuations and I detected a more planned strategic plan moving forward more so than in the past.

Yes WF they do and may be for a couple of main reasons. They love the science and ant to buy it outright and/or it may offer a more attractive approach to replace/enhance/complement their own R&D in a particular area of focus like immuno oncology. It could be that they have agreements in place already at a very early pre clinical stage and are just progressing the deal with milestones. My guess would be until 2015/16 they realised that to attract big pharma interest they needed to try a different approach and get the validation to progressvthings. Since then the CRUK and BionTech validations have helped enormously and certain during that period other pharma would have been in contact but we know these deals can take 18-24months. I think SCLP decided that as they have full confidence in the platforms and to achieve full value they need to demonstrate the next stage ie Moditope in humans and SCIB 1/Combo. Once those results are in then the sky is the limit but particularly in the case of Moditope there is an element of risk of not replicating the pre clinical work albeit one I consider well worth one taking. No one should consider that anything is guaranteed and our current valuation reflects this

Evening Crumbs/WF I remember listening to that specific bit and consider number 2 scenario most likely. Another key bit was CH stating we are in business of curing humans and not mice and his earlier comment about big pharma being interested at phase 2 stage as it considerably reduces the risk. He also stated about now having a ringside seat at the big pharma table and they will await the results with considerable interest. Yes sometimes big pharma will pay huge amounts for pre clinical assets but SCLP must prove Moditope is safe and effective in humans not humanised mice. I am sure SCLP are very confident and the chance of repeating the pre clinical success is very high but it needs to be demonstrated before big pharma are likely to take the plunge. But if it iOS replicated in humans then they will be fighting amongst themselves to acquire the asset imo and the game really is on

Thanks for response and makes sense. Re my � memory response� should have read good results and � no� should not have been written.Issues with predictive text and too many dogs on house pestering me for attention when posting. Konar summed up my thoughts better and yes b a much better thought. ATB

Yes RW.Never heard that one before lol. C7- yes Royal Wedding was highlight of my day as it turned out. You had better of first half and we did much better in 2nd.Not much between 2 teams and overall Chelsea defended much better so credit where it is due. Obviously both teams wanted to win but sure both will be disappointed with seasons efforts for different reasons due to City/Liverpool etc. As RG said at AGM the PIs often find out details of patent status before SCLP so sure RNS will come in time but if delayed may even come as part of general update which may reveal a bit more. More than 6 months since Last AGM and much progress made and moving forward. Wonder if we will get an update on patients still on SCIB 1.Know Trial has stopped but presume they have the option of continued treatment or even if a memory response is still achieving no good results in those people who may have stopped treatment.

Nomlungu Very interesting read and see no reason why they can�t provide some of the answers towards combatting AMR. Thinknthe big issue is highlighted in the article. Phages cannot pass that test, because any one phage will only work on a subset of patients.-so large scale clinical trials are the issue. However legislation such as 21st Century Cures Act can help obviate the need for these larger trials and may help with phage treatment along with some of the personalised cancer treatments so there is a bit of crossover as highlighted by the highlighting of the CART treatments. ATB